With the growth of Vietnam’s economy and population, the country’s pharmaceutical market has become increasingly important. Vietnam is classified by the IQVIA Institute as a “pharmerging” market—a developing country with a relatively low per capita income but strong market growth potential for prescription medication. According to statistics from the Drug Administration of Vietnam (DAV), the sector will continue to see double-digit growth for the next five years, offering many opportunities for development.
The statistics presented in this report on pharmaceutical patent filings in Vietnam reveal some trends, challenges, and opportunities in this important market.
Please click the link below to view the entire report.